Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Browse by Series:

FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year

Gina Columbus
Published: Thursday, Feb 09, 2017



Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
SELECTED
LANGUAGE
Slider Left
Slider Right


Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x